在胃肠道,胰腺,胰腺神经内分泌新生体中表达和功能成像Delta-Like Ligand 3表达
Rohit Thummalapalli1, Salomon Tendler1, Joanne F Chou2
1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
德尔塔样联体3 (DLL3) 在大多数胃肠道胰腺神经内分泌癌 (GEP NECs) 和一些高度胰腺神经内分泌瘤 (PanNETs) 中表达. 针对DLL3的成像显示了这些神经内分泌癌症类型的前景.
科学领域:
- 在瘤学瘤学.
- 分子成像学分子成像学
- 癌症生物学 癌症生物学
背景情况:
- 德尔塔样联体3 (DLL3) 是神经内分泌癌症的一个新目标.
- 在胃肠道胰腺神经内分泌瘤 (GEP NENs) 中DLL3表达的特征不佳.
研究的目的:
- 为了研究DLL3在胃肠道胰腺神经内分泌瘤 (GEP NENs) 的表达.
- 评估DLL3向免疫PET-CT成像在GEP NEN中的可行性.
主要方法:
- 在379个GEP NEN瘤样本上进行了DLL3免疫组织化学 (IHC).
- [89Zr]Zr-DFO-SC16.56 免疫PET-CT成像在6名DLL3阳性GEP NEN患者中进行.
主要成果:
- 在71%的GEP神经内分泌癌 (NECs) 和40%的3级胃肠道胰腺神经内分泌瘤 (GEP NETs) 中发现DLL3表达.
- DLL3阳性与晚期G3泛网患者的死亡率增加相关.
- 免疫-PET-CT成功可视化了5/6名患者的DLL3-avid病变,包括GEP NEC和G3 PanNET.
结论:
- DLL3表达在大多数GEP NEC和高档PanNET的子集中.
- 以DLL3为目标的成像显示了GEP NEC和高档PanNET的潜力.
- 对于这些GEP NEN亚型来说,DLL3是一个有前途的治疗标.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
09:06Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
Published on: February 3, 2023
相关概念视频
Hormonal Regulation
IP3/DAG Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Regulation of the Digestive System
The effectors in this regulation system are glands and smooth muscles. Activation of these...
Hormones Secreted by the Stomach
Each of these hormones secreted by different enteroendocrine cells plays a unique role in digestion. Here are a few examples:
Intestinal Phase of Digestion
The arrival of the chyme in the small intestine distends the duodenum, which triggers the enterogastric reflex. This distension...
